Dermira (DERM) Misses Q1 EPS by 31c

Dermira (NASDAQ: DERM) reported Q1 EPS of ($0.53), $0.31 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $13 million versus the consensus estimate of $14.25 million.

For earnings history and earnings-related data on Dermira (DERM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• United Community Banks sells equipment finance unit for $1.9 billion
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist